NSAID Use May Lower Skin Cancer Risk:
Non steroidal anti-inflammatory drugs (NSAIDs) may help reduce risk of developing squamous cell carcinoma and malignant melanoma, according to a new study published online in Cancer.
Doctors in Denmark analyzed medical records from northern Denmark from 1991 through 2009 and identified 1,974 diagnoses of squamous cell carcinoma, 13,316 diagnoses of basal cell carcinoma, and 3,242 diagnoses of malignant melanoma. They compared information, including NSAID prescription data, from these patients with that of 178,655 individuals without skin cancer.
Those individuals who filled more than two prescriptions for NSAIDs had a 15% decreased risk for developing squamous cell carcinoma, and a 13% decreased risk for developing malignant melanoma than those who filled two or fewer NSAID prescriptions, the study showed. The longer participants took the NSAIDS, the lower their risk for these Skin Cancer Removal.
Exactly how, or even if, NSAIDS affect skin cancer risk is not fully understood, but these drugs target the cyclooxygenase-2 (Cox-2) enzyme, which is also expressed by certain cancers. “We hope that the potential cancer-protective effect of NSAIDs will inspire more research on skin-cancer prevention,” says Jóhannesdóttir, in a press release. “Also, this potential cancer-protective effect should be taken into account when discussing benefits and harms of NSAID use.”
Think that you may have a worrisome looking mole or growing spot? Call the team at TruYou plastic surgery for a consultation and we can remove the lesion and have it sent for biopsy. Click here to learn more Skin Cancer Removal.